reports
BioArctic AB: 2 directors
Two Directors at BioArctic AB sold 2,400,000 shares at 300.000SEK. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
- Jean Danjou
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
TYRES NOKIAN RENKAAT OYJ
EL ESSILORLUXOTTICA SA
BRBY BURBERRY GROUP PLC
KER KERING SA
MBB MBB INDUSTRIES SE
01913 PRADA S.P.A.
RIEN RIETER HOLDING AG
SLIGR SLIGRO FOOD GROUP N.V.
MONC MONCLER SPA
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
COFA COFACE SA
UMI UMICORE
- Jean Danjou
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
TYRES NOKIAN RENKAAT OYJ
EL ESSILORLUXOTTICA SA
BRBY BURBERRY GROUP PLC
KER KERING SA
MBB MBB INDUSTRIES SE
01913 PRADA S.P.A.
RIEN RIETER HOLDING AG
SLIGR SLIGRO FOOD GROUP N.V.
MONC MONCLER SPA
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
COFA COFACE SA
UMI UMICORE
- Anthony Dick
- Michael Foundoukidis
- Anthony Dick
- Michael Foundoukidis
- ABGSC Online Gaming Research
- Oscar Rönnkvist
- Simon Jönsson
- ABGSC Online Gaming Research
- Oscar Rönnkvist
- Simon Jönsson
- ABGSC Online Gaming Research
- Oscar Rönnkvist
- Simon Jönsson
- ABGSC Online Gaming Research
- Oscar Rönnkvist
- Simon Jönsson
- ABGSC Online Gaming Research
- Oscar Rönnkvist
- Simon Jönsson
- ABGSC Online Gaming Research
- Oscar Rönnkvist
- Simon Jönsson
- Jerôme Bodin
EVT EVOTEC SE
FGA FIGEAC AERO SA
DEC JCDECAUX SA
TYRES NOKIAN RENKAAT OYJ
ALDEL DELFINGEN INDUSTRY SA
KCO KLOECKNER & CO SE
VLS VALNEVA SE
LNA LNA SANTE SA
BOSS HUGO BOSS AG
BON BONDUELLE SCA
WPP WPP PLC
FAE FAES FARMA S.A.
VLK VAN LANSCHOT KEMPEN NV CERT. OF SHS
RIEN RIETER HOLDING AG
FDR FLUIDRA S.A.
TWEKA TKH GROUP N.V. CERT
JUN3 JUNGHEINRICH AG PREF
IDR INDRA SISTEMAS S.A. CLASS A
PSG PROSEGUR COMPANIA DE SEGURIDAD SA
CASH PROSEGUR CASH SA
AMAG AMAG AUSTRIA METALL AG
SANT S&T AG
GRP GREENCOAT RENEWABLES
HAG HENSOLDT AG
AG1 AUTO1 GROUP
PLNW PLANISWARE
SPG SPRINGER NATURE AG & CO. KGAA
HAVAS HAVAS N.V
- Jerôme Bodin
EVT EVOTEC SE
FGA FIGEAC AERO SA
DEC JCDECAUX SA
TYRES NOKIAN RENKAAT OYJ
ALDEL DELFINGEN INDUSTRY SA
KCO KLOECKNER & CO SE
VLS VALNEVA SE
LNA LNA SANTE SA
BOSS HUGO BOSS AG
BON BONDUELLE SCA
WPP WPP PLC
FAE FAES FARMA S.A.
RIEN RIETER HOLDING AG
FDR FLUIDRA S.A.
TWEKA TKH GROUP N.V. CERT
JUN3 JUNGHEINRICH AG PREF
IDR INDRA SISTEMAS S.A. CLASS A
PSG PROSEGUR COMPANIA DE SEGURIDAD SA
CASH PROSEGUR CASH SA
AMAG AMAG AUSTRIA METALL AG
SANT S&T AG
GRP GREENCOAT RENEWABLES
HAG HENSOLDT AG
AG1 AUTO1 GROUP
PLNW PLANISWARE
SPG SPRINGER NATURE AG & CO. KGAA
HAVAS HAVAS N.V
- Anthony Dick
- Michael Foundoukidis
- Anthony Dick
- Michael Foundoukidis
- Martin Arnell
Evolution (Buy, TP: SEK1100.00) - Play it right in fencing
Despite intact 2025 EBITDA margin guidance, a soft Q1 and near-term uncertainties made us cut our 2025–2027e EPS by c10%. The step-up of focus on regulated markets supports the long-term case, although it comes with costs near-term. We reiterate our BUY but have cut our target price to SEK1,100 (1,440). We expect buybacks, expansion, new games, and growth improvements to strengthen the story later in 2025.
- ABGSC Online Gaming Research
- Oscar Rönnkvist
- Simon Jönsson
- ABGSC Online Gaming Research
- Oscar Rönnkvist
- Simon Jönsson
- ABGSC Online Gaming Research
- Oscar Rönnkvist
- Simon Jönsson
- Geir Hiller Holom
Arctic Bioscience (No_rec, TP: NOK) - HeROPA-trial 1-year read-out
Arctic Bioscience announced 52-week results for the HeROPA trial (mild to moderate psoriasis). The results did not include detailed data and only a very limited number of the predefined secondary endpoints were described. It plans to present the full set of data from the study when the Clinical Study Report is ready in June. Based on the lack of detailed data, it is hard to draw conclusions, but based on what was presented, we view this as another setback for the company.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.